mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.049 |
0.4 |
mRNA |
compound 1B |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.4 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |